# Fountain Life

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fountain-life

- Industry: Healthcare
- Headquarters: Orlando, US
- Website: www.fountainlife.com/
- Total disclosed funding: $18M
- Latest round: Series B (Aug 13, 2025)
- Investors on record: 1

## About

Based in Florida, US, and founded in 2019 by co-founders Tony Robbins, Peter Diamandis, and Dr. Bob Hariri, Fountain Life, LLC operates as a preventative health and longevity company that uses cutting-edge Artificial Intelligence (AI) to collect data and gain insights into the human body. In August 2025, Fountain Life, LLC raised USD 18 million in series B funding led by Eos Ventures, with participation from the company's management. Fountain Life, LLC provides diagnostic testing to identify conditions such as cancer, cardiac, metabolic, and neurodegenerative diseases at the earliest stages. The diagnostic testing includes an AI coronary artery scan, full Body MRI, cancer detection test, executive blood panel, whole genome sequencing, gut microbiome analysis, and DEXA bone density scan. In addition, the company offers Life’s Apex membership that provides annual access to early-detection technology, advanced treatment plans, and concierge medical service that turn the tables on cancer, heart disease, diabetes, dementia, and other looming illnesses. The company will use the August 2025 funding to open more longevity performance centers across the US.

## Funding rounds

- Series B, Aug 13, 2025, $18M — Eos Ventures

## Investors

- Eos Ventures (https://capitalatlas.ai/funds/eos-ventures) — Series B